Skip to main content

75 publications

Name Date Type Actions

Buyback programs - July

Monthly communication regarding buyback programs 
 

22/08/2023 Description of buyback programs

Mastaplex and Vetoquinol announce distribution agreement

Mastaplex Ltd (New Zealand, unlisted) and Vetoquinol (VETO: France Euronext) are pleased to announce an extension of their exclusive distribution agreement for Mastatest..

27/07/2023 Press releases communication

Rapport financier semestriel 2022 (french)

Rapport financier semestriel 2022 (french)

26/06/2023 Half Year Report

Growth driven by innovation

Ever since the company was founded in 1933, innovation has been a major component of Vetoquinol's development strategy.

13/06/2023 Press releases communication

3rd generation appointed chairman of the board of directors of VETOQUINOL SA

At the Combined General Meeting it was also announced that Mr. Etienne Frechin will resign as Chairman of the Board of Vetoquinol, effective 1st July 2023. Mr. Etienne Frechin will remain a Director of the company, hence continuing to share his broad experience. On 25 May 2023, the Board of Directors appointed Mr. Matthieu Frechin, Chief Executive Officer of the Group, as Chairman of the Board of Directors of Vetoquinol effective 1st July 2023.

25/05/2023 Press releases communication

Essential products

Essential products for the most common needs

27/04/2023 Press releases communication

Worlds Top 10

The animal health company is firmly established in the world's Top 10. 

27/04/2023 Press releases communication

A visionary strategy

The key steps of a visionary strategy

03/04/2023 Press releases communication

Serving animal Health - 90 years

Serving animal Health for over 90 years

06/03/2023 Press releases communication

Buyback programs - February 2023

Monthly communication regarding buyback programs

06/03/2023 Description of buyback programs